Lupus (SLE): open trials in Hong Kong SAR China

• NCT06711887

  Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Tuenmen

  Registry updated 2026-10-13

• NCT02954939

  The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

  Trial Treatment · The University of Hong Kong

  Queen Mary Hospital, Hong Kong

  Registry updated 2024-12-16

• NCT06155604

  SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

  Trial Treatment · Phase 2 · The University of Hong Kong

  Queen Mary Hospital, Hong Kong

  Registry updated 2024-12-16

All Lupus (SLE) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error